Insider · CIK 0001814150

Coen Stacy Ann

Reports to the SEC for 2 companies · HOUSTON, TX

sec.gov

Transactions

Companies

Filings

CIK

0001814150

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-12	FBLGFibroBiologics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2024-08-27	FBLGFibroBiologics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2024-02-12	ImmunoGen, Inc.Restricted Stock UnitD Disposition to Issuer	SVP & CHIEF BUSINESS OFFICER	DDisposition to Issuer	−28.7K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Restricted Stock UnitD Disposition to Issuer	SVP & CHIEF BUSINESS OFFICER	DDisposition to Issuer	−39.3K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP & CHIEF BUSINESS OFFICER	DDisposition to Issuer	−151K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP & CHIEF BUSINESS OFFICER	DDisposition to Issuer	−303K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP & CHIEF BUSINESS OFFICER	DDisposition to Issuer	−65K sh	—	—	0
2024-02-12	ImmunoGen, Inc.D Disposition to Issuer	SVP & CHIEF BUSINESS OFFICER	DDisposition to Issuer	−73.3K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP & CHIEF BUSINESS OFFICER	DDisposition to Issuer	−258K sh	—	—	0
2024-02-05	ImmunoGen, Inc.S Sale	SVP & CHIEF BUSINESS OFFICER	SSale	−4,583 sh	$29.30	−$134K	73,274
2024-02-02	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+14.4K sh	—	—	77,857
2024-02-02	ImmunoGen, Inc.Restricted Stock UnitM Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−14.4K sh	—	—	28,700
2024-02-01	ImmunoGen, Inc.Restricted Stock UnitA Award	SVP & CHIEF BUSINESS OFFICER	AAward	+39.3K sh	—	—	39,293
2023-12-29	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+30K sh	$5.32	+$160K	63,140
2023-12-29	ImmunoGen, Inc.A Award	SVP & CHIEF BUSINESS OFFICER	AAward	+367 sh	$16.01	+$5,875.67	63,507
2023-12-29	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−30K sh	—	—	303,465
2023-11-30	ImmunoGen, Inc.S Sale	SVP & CHIEF BUSINESS OFFICER	SSale	−3,826 sh	$29.20	−$112K	33,140
2023-11-17	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−76K sh	—	—	76,787
2023-11-17	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+2,200 sh	$4.92	+$10.8K	39,166
2023-11-17	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+76K sh	$7.69	+$585K	115,189
2023-11-17	ImmunoGen, Inc.S Sale	SVP & CHIEF BUSINESS OFFICER	SSale	−78.2K sh	$16.05	−$1.26M	36,966
2023-11-17	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−2,200 sh	—	—	48,823
2023-11-16	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−3,200 sh	—	—	51,023
2023-11-16	ImmunoGen, Inc.S Sale	SVP & CHIEF BUSINESS OFFICER	SSale	−4,100 sh	$16.01	−$65.6K	36,966
2023-11-16	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−900 sh	—	—	152,810
2023-11-16	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+3,200 sh	$4.92	+$15.7K	40,166
2023-11-16	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+900 sh	$7.69	+$6,921	41,066
2023-11-15	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−5,300 sh	—	—	153,710
2023-11-15	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+21K sh	$4.92	+$103K	57,952
2023-11-15	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+5,300 sh	$7.69	+$40.8K	63,252
2023-11-15	ImmunoGen, Inc.S Sale	SVP & CHIEF BUSINESS OFFICER	SSale	−26.3K sh	$16.01	−$421K	36,966
2023-11-15	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−21K sh	—	—	54,223
2023-09-08	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+26K sh	$7.69	+$200K	36,966
2023-09-08	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−26K sh	—	—	159,010
2023-08-09	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+100K sh	$4.92	+$493K	111,170
2023-08-09	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−100K sh	—	—	75,209
2023-08-09	ImmunoGen, Inc.S Sale	SVP & CHIEF BUSINESS OFFICER	SSale	−100K sh	$14.20	−$1.42M	10,960
2023-08-04	ImmunoGen, Inc.S Sale	SVP & CHIEF BUSINESS OFFICER	SSale	−80.3K sh	$17.05	−$1.37M	10,960
2023-08-04	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−80.3K sh	—	—	175,419
2023-08-04	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+80.3K sh	$4.92	+$395K	91,286
2023-08-02	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	−4,255 sh	—	—	255,745
2023-08-02	ImmunoGen, Inc.M Exercise/Conversion	SVP & CHIEF BUSINESS OFFICER	MExercise/Conversion	+4,255 sh	$4.92	+$20.9K	15,215
2023-08-02	ImmunoGen, Inc.S Sale	SVP & CHIEF BUSINESS OFFICER	SSale	−4,255 sh	$18.12	−$77.1K	10,960
2023-06-30	ImmunoGen, Inc.A Award	SVP & CHIEF BUSINESS OFFICER	AAward	+3,792 sh	$4.05	+$15.4K	10,960
2023-02-03	ImmunoGen, Inc.Stock Option (right to buy)A Award	SVP & CHIEF BUSINESS OFFICER	AAward	+246K sh	—	—	245,900
2023-02-03	ImmunoGen, Inc.Restricted Stock UnitA Award	SVP & CHIEF BUSINESS OFFICER	AAward	+41K sh	—	—	41,000
2022-11-14	ImmunoGen, Inc.Stock Option (Right to Buy)A Award	SVP & CHIEF BUSINESS OFFICER	AAward	+60K sh	—	—	90,000
2022-06-30	ImmunoGen, Inc.A Award	SVP & CHIEF BUSINESS OFFICER	AAward	+3,342 sh	$3.83	+$12.8K	7,168
2022-05-20	ImmunoGen, Inc.Stock Option (Right to Buy)A Award	SVP & CHIEF BUSINESS OFFICER	AAward	+30K sh	—	—	30,000
2022-02-04	ImmunoGen, Inc.Common Stock (right to buy)A Award	SVP & CHIEF BUSINESS OFFICER	AAward	+333K sh	$5.32	+$1.77M	333,465

Recent filings

Accepted (ET)
Jun 124
Coen Stacy Ann0001641172-25-014931
SEC(opens sec.gov)
Aug 274
Coen Stacy Ann0001493152-24-034066
SEC(opens sec.gov)
Feb 124
Coen Stacy Ann0001104659-24-014711
SEC(opens sec.gov)
Feb 64
Coen Stacy Ann0001415889-24-002873
SEC(opens sec.gov)
Feb 54
Coen Stacy Ann0001415889-24-002761
SEC(opens sec.gov)
Jan 34
Coen Stacy Ann0001415889-24-000381
SEC(opens sec.gov)
Dec 54
Coen Stacy Ann0001415889-23-015909
SEC(opens sec.gov)
Nov 174
Coen Stacy Ann0001415889-23-015268
SEC(opens sec.gov)

Companies

Address

C/O FIBROBIOLOGICS, INC. 455 E. MEDICAL CENTER BLVD. SUITE 300

HOUSTON, TX, 77598